Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Hiroo Kuwahara"'
Autor:
Minoru Takii, Hiroo Kuwahara, Mitsunari Habukawa, Hiroshi Hiejima, Nozomu Kotorii, Hayato Ohshima, Naohisa Uchimura
Zolpidem is widely prescribed for the treatment of insomnia and is used to both induce and maintain sleep. Previously, zolpidem was thought to have low abuse potential; however, several reports have documented dose escalation and abuse in the past tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42d545c9076488a705bd3b6e240a163d
https://europepmc.org/articles/PMC6223559/
https://europepmc.org/articles/PMC6223559/
Autor:
Naohisa Uchimura, Tetsuo Shimizu, Makoto Uchiyama, Shigeru Chiba, Hiroo Kuwahara, Atsushi Kamijo, Yuichi Inoue
Publikováno v:
Sleep Medicine. 13:1247-1253
To evaluate the efficacy and dose-response effect of eszopiclone on sleep latency and sleep maintenance in Japanese patients with primary insomnia.In this randomized, double-blind, five-way crossover study, 72 patients received placebo, eszopiclone 1
Autor:
Mitsukuni Murasaki, Masako Kohsaka, Kunihisa Kamikawa, Takashi Kanemura, Hiroo Kuwahara, Yoshiro Sugita, Hideki Uno, Mitsutaka Taniguchi, Atsushi Ogawa, Akira Mikami
Publikováno v:
Expert Review of Neurotherapeutics. 11:1389-1397
The aim of this study was to evaluate the efficacy and safety of ramelteon 4, 8, 16 or 32 mg and placebo in Japanese patients with chronic insomnia using a randomized, double-blind, five-period crossover design. A total of 65 Japanese patients with c
Autor:
Y. Sugita, Yoichi Tsuji, Noriko Fukuda, Katuhiro Inoue, Hiroo Kuwahara, Masayosi Terashima, Einosuke Koga, Masako Kousaka, Toshinori Kobayashi, Sunao Uchida, Kazuhiko Fukuda, Tadao Hori, Shuichiro Shirakawa
Publikováno v:
Psychiatry and Clinical Neurosciences. 55:305-310
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 12:105-110
A survey of respiratory dyskinesia for 248 inpatients receiving neuroleptic drugs was undertaken to explore the prevalence and subtype of respiratory dyskinesia using computer analysis of spirograph data monitored by both a Somniprobe nasal thermisto
Publikováno v:
The Kurume Medical Journal. 43:243-248
An automatic sleep analysis system using a super mini-computer was developed. The system improved and expanded the data processed by the mini-computer. It had the following features: 1) wave-forms were collected and analyzed at a high speed (reproduc
Autor:
Naohisa, Uchimura, Hiroo, Kuwahara, Yuji, Kumagai, Kazuo, Mishima, Yuichi, Inoue, Craig R, Rayner, Stephen, Toovey, Brian E, Davies, Yoshio, Hosaka, Masaichi, Abe, Eric P, Prinssen
Publikováno v:
Basicclinical pharmacologytoxicology. 109(4)
Influenza-associated neuropsychiatric symptoms include parasomnias such as sleepwalking which is a common sleep disturbance in childhood. Oseltamivir is a widely used antiviral drug for influenza. Recently, sleepwalking-like events have been reported
Autor:
Yasunori Uchida, Tadashi Nishikawa, Hiroo Kuwahara, Akira Tsuda, Masatoshi Tanaka, Itsuyuki Koga
Publikováno v:
Psychiatry and Clinical Neurosciences. 46:665-672
One acute and one tardive akathisia patients, respectively, and 10 neuroleptic-treated schizophrenic patients were injected with biperiden 5 mg or saline and the response to anticholinergics was monitored by microvibration (MV) as an indicator of mus
Autor:
Tadashi Nishikawa, Hiroo Kuwahara, Masatoshi Tanaka, Itsuyuki Koga, Yasunori Uchida, Akira Tsuda
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 5:363-368
Ceruletide, a potent analogue of cholecystokinin, was administered by injection to eight schizophrenics treated with neuroleptics. We examined the dose–response effect on microvibration (MV) recorded from the chin of these patients. After 15 min of
Autor:
Iwao Nose, Naohisa Uchimura, Yuji Hashizume, Tetsu Ohyama, Hiroo Kuwahara, Nozomu Kotorii, Toru Nakajima, Hisao Maeda, Kunihiko Hayash, Mitsunari Habukawa
Publikováno v:
Progress in neuro-psychopharmacologybiological psychiatry. 30(1)
This study was conducted to determine the effect of zolpidem (ZOL) 10 mg orally on the sleep architecture and the next-morning residual effect in patients with non-organic insomnia (ICD-10) as compared to the effect of brotizolam (BTM) 0.25 mg orally